PubHive, a provider of cloud-based literature management and safety intelligence tools for the life sciences sector, has launched a new AI-powered translation feature for its PubHive Navigator™ platform. The capability enables users to translate scientific literature from multiple languages into English within the platform, supporting global pharmacovigilance, medical affairs, and regulatory compliance processes.
The addition addresses a common challenge for international safety and medical teams, who frequently require manual translation of non-English literature to meet regulatory requirements, detect safety signals, and conduct medical reviews. By automating translation, the platform aims to reduce operational delays and reliance on third-party services.
The new feature allows literature to be translated instantly, facilitating faster safety reviews, literature screening, and regulatory reporting. According to PubHive, the models are specifically adapted for scientific and clinical language to maintain consistency in translation quality.
Use cases for the feature include local literature monitoring, medical information management, regulatory submission support, and competitive intelligence. Teams can now incorporate non-English publications into workflows for safety surveillance, adverse event detection, and R&D-related activities. The platform also supports translation of key opinion leader publications to inform regional engagement strategies in medical affairs.
PubHive states that the translation functionality is designed to improve global collaboration by enabling multilingual content review directly within existing workflows.
Click here to read the original press release.
More News in this Theme
